Cognitive & Mood Dietary supplement

Alpha-GPC

Alpha-Glycerophosphocholine · L-Alpha Glycerylphosphorylcholine · GPC

Evidence: Studied in humans. Example dose: finalize with a provider. Not a fact-check stamp.

300mg – 300-600 mg Oral Daily (or pre-workout for acute effect)

Alpha-GPC (alpha-glycerophosphocholine, also called L-alpha-glycerylphosphorylcholine or choline alfoscerate) is a highly bioavailable choline-containing compound that crosses the blood-brain barrier readily. Unlike other choline sources (choline bitartrate, lecithin, phosphatidylcholine), Alpha-GPC delivers ~40% by weight as bioavailable choline directly into systemic circulation and effectively to the brain. Originally developed as a pharmaceutical in Italy (where it remains a prescription drug for Alzheimer's and stroke recovery), Alpha-GPC is sold over-the-counter as a supplement in the US.

Quick Start

Route

Oral

Start low

300mg Oral

Frequency

Daily (or pre-workout for acute effect)

Timing

Anytime

300-600mg daily for chronic cognitive support; 600mg taken 30-60 minutes pre-exercise for acute athletic/GH effect. Take with food if GI sensitive. Best paired with Uridine + DHA for full neuronal membrane support (Mr. Happy Stack).

❋

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first

Conservative start

300mg · Oral · Daily (or pre-workout for acute effect)

conservative starter

300mg

Daily (or pre-workout for acute effect)

Standard

Power & Focus Edge

300-600 mg · Oral · Daily

human clinical trial · Bellar et al. 2015 (J Int Soc Sports Nutr)

Crosses the blood-brain barrier rapidly to supply choline for acetylcholine synthesis.

300-600 mg

Daily

◆

How it works

Alpha-GPC's primary mechanism is delivery of bioavailable choline to the brain for acetylcholine synthesis. Once absorbed, Alpha-GPC is cleaved into glycerophosphate + choline; the choline crosses the blood-brain barrier via the choline transporter (CHT1) and is converted to acetylcholine by choline acetyltransferase. The increased acetylcholine availability supports cognitive functions reliant on cholinergic neurotransmission - especially memory consolidation, attention, and motor control.

Beyond simple choline donation, Alpha-GPC's glycerophosphate backbone supports phosphatidylcholine biosynthesis (CDP-choline pathway), contributing to neuronal membrane integrity and repair. This dual contribution (acetylcholine + phosphatidylcholine) distinguishes Alpha-GPC from simpler choline forms that primarily support acetylcholine without the membrane support.

The growth hormone secretagogue effect is mediated through cholinergic activation of the hypothalamic-pituitary axis - increased acetylcholine inhibits somatostatin (the GH-suppressing hormone) and stimulates GHRH release. Acute Alpha-GPC dosing (600-1000mg) reliably produces 3-5x baseline GH spike within 30-60 minutes, contributing to anabolic/recovery effects in athletic contexts. Additional mechanisms include direct effects on dopaminergic neurotransmission and modest reduction of age-related cholinergic neuron loss in animal models.

What to expect

Early

Days 1–7

30-60 minutes: Acute cognitive effects.

Evidence

HumanPresent

AnimalPresent

In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Dose boundary: a randomized trial used 400 mg capsules three times daily, not the card’s 300 mg once-daily regimen.

In this multicenter, double-blind, randomized, placebo-controlled trial, patients affected by mild to moderate dementia of the Alzheimer type were treated with CA (400-mg capsules) or placebo capsules, 3 times daily, for 180 days.

Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical therapeutics · 2003 · PMID 12637119

Evidence scope. Human RCT; mild-to-moderate Alzheimer's dementia patients (n=261); oral 400 mg three-times-daily for 180 days — differs from the card's 300 mg once-daily regimen.

Mechanism/effect: choline alfoscerate is a cholinergic precursor studied for cognitive impairment.

This study assessed the efficacy and tolerability of the cholinergic precursor choline alfoscerate (CA) in the treatment of cognitive impairment due to mild to moderate AD.

Evidence scope. Human RCT; Alzheimer's-dementia-related cognitive impairment specifically, not cognitive impairment of any other etiology.

Oral PK boundary: healthy volunteers received 1,200 mg oral choline alfoscerate in a bioequivalence study.

Subjects were orally treated with 1,200 mg of test or reference choline alfoscerate (400 mg × three doses) formulation.

Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers. Drug design, development and therapy · 2019 · PMID 31040642

Evidence scope. Human; healthy Korean male volunteers; single-dose oral PK/bioequivalence crossover study, not a disease population or efficacy trial.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Exact dose/frequency: 300 mg orally once daily or pre-workout. The checked abstracts used 1,200 mg total doses; none verified 300 mg once daily.

Primary safety concern, including the card’s observational stroke-risk statement. No checked abstract directly supported that card-specific safety claim at 300 mg/day.

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

Caffeine / L-TheanineCompatible. Acute Alpha-GPC complements stimulant cognitive effects.

Lion's ManeLion's Mane supports NGF; Alpha-GPC supports cholinergic neurotransmission. Compatible cognitive stack.

Uridine MonophosphateUridine + Alpha-GPC + DHA together fuel the Kennedy cycle for phosphatidylcholine + phosphatidylethanolamine synthesis. Maximum synaptic membrane support.

DHA (Omega-3)DHA is direct phospholipid component; Alpha-GPC provides choline for phosphatidylcholine. Complementary phospholipid synthesis.

Keep separate

Anticholinergic Medications (Antihistamines, Antipsychotics, Atropine)Alpha-GPC's cholinergic enhancement opposes anticholinergic drugs - reduced therapeutic effect of either possible.

Acetylcholinesterase Inhibitors (Donepezil, Rivastigmine)Combining choline source + AChE inhibitor could excessively elevate acetylcholine. Discuss with prescribing physician.

ScopolamineDirect antagonism - Alpha-GPC may reduce scopolamine effectiveness.

Bipolar Disorder (caution)Theoretical: cholinergic enhancement may worsen depressive episodes in bipolar (cholinergic-adrenergic balance theory). Limited evidence.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

Pharmacokinetics

Illustrative plasma concentration · 20 h

Half-life

~4-5 hours

Peak · Tmax

~1-3 hours

Oral

Elimination

~12-24 hours

Bioavailability

High (~95%) oral bioavailability. Crosses BBB readily. Effective choline delivery superior to choline bitartrate or lecithin.

Duration of action

Acute cognitive effects 4-6 hours per dose. Chronic effects build with consistent daily intake.

Clearance

Hepatic metabolism, choline incorporation into phosphatidylcholine and acetylcholine pools. Renal excretion of metabolites.

Storage. Store at room temperature (20-25C) in a cool, dry place. Alpha-GPC is hygroscopic - keep tightly sealed and protected from moisture. Capsules shelf-stable for 18-24 months. Bulk powder may clump with humidity exposure.

Regulatory status

Classified as a dietary supplement in the US. Available widely over the counter. Prescription pharmaceutical in Italy and other EU countries (registered for Alzheimer's, vascular dementia, stroke recovery). Generally Recognized as Safe at typical supplement doses.

Put it to work

Calculate, log & track

Open Alpha-GPC straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Alpha-GPC in the app →

Go deeper

The guide & community

The complete Alpha-GPC walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗

Open in app Community